IVD Technology

November 1998
Selected Contents

Editor's Page

And another thing . . .

COVER STORY:

DNA-chip technologies Part 2: State-of-the-art and competing technologies
by Cliff Henke

DNA microarray product development is proceeding with one underlying principle: fast is not fast enough. This is the second of a three-part series on the emerging technology.

Also:

• Cepheid bridges the sample-volume gap
  —Kurt Petersen
  
• Microarray technology development
  —Deepak Thakkar at Genometrix
  
• Caliper harnesses electrokinetics
  —Anne R. Kopf-Sill>
  
• Vysis prepares to launch Genosensor array technology
  —Uwe Müller
  
• Microtechnology development at PE Applied Biosystems
  —Evelyn Shulakoff

Measuring microsphere binding capacity
by Joseph M. Duffy, John V. Wall, Mary B. Meza, and Laura J. Jenski

Assays to determine the binding capacity of streptavidin-coated magnetic microspheres can provide critical information about their suitability for IVD applications.

Regulations and standards:
Free-speech decision could advance off-label IVD promotion
by Jeffrey N. Gibbs

IVD Technology News

• Bayer buys Chiron division
• Lab automation demand steady
• MDEA accepting entries
• Xanthon strengthens financial position
• Lifescan issues glucose meter recall
• Better focus for fluorescent microscopy